Weis Shirley A
SEC Form 4 insider trading activity
Weis Shirley A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Weis Shirley A is listed as Director at Pediatrix Medical Group, Inc. Inside the rolling window, Weis Shirley A reported no open-market purchases and 1 open-market sale totaling $856K in MD.
Companies traded
Other insiders at MD
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$856K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Weis Shirley A made?
Weis Shirley A has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.
Which companies does Weis Shirley A trade?
Weis Shirley A has filed SEC Form 4 disclosures for 1 company, including MD.
When was Weis Shirley A's most recent SEC Form 4 filing?
Weis Shirley A's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Weis Shirley A's total buy and sell value in the current window?
Inside the rolling retention window, Weis Shirley A bought $0 and sold $856K based on SEC Form 4 filings.
What was Weis Shirley A's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,028 MD shares on 2026-05-13, worth $856K, per SEC Form 4 filings.